• HOME
  • FAQs
  • NEWS
  • FULL PRESCRIBING INFORMATION
  • About VETMEDIN
    • Dual-acting inodilator
    • VETMEDIN
      in CHF
    |
  • About CHF|
    • Signs of CHF
    • AVVI
    • DCM
    • Diagnosing CHF
  • Act Now—Use VETMEDIN|
    • CHF treatment
    • Importance of acting now
    • 2009 ACVIM consensus statement
  • VETMEDIN Efficacy|
    • VetSCOPE
    • QUEST
  • Safety and Dosing|
    • Record of safe use
    • Dosage
  • VETMEDIN Programs
  • Signs of CHF
  • AVVI
  • DCM
  • Diagnosing CHF
    • Clinical history
    • Physical examination
    • Cardiac and pulmonary auscultation
    • Thoracic radiographs
    • Additional diagnostic tests

USEFUL LINKS

  • VETMEDIN Full Prescribing
    Information
  • Cardiac Education Group
  • YourDogsHeart.com
  • Boehringer Ingelheim Vetmedica, Inc.
  • American College of Veterinary
    Internal Medicine

Clinical history

Signalment is an important consideration when diagnosing congestive heart failure (CHF) in dogs. In particular, it is important to assess the following factors:

  • Age: Middle-aged and older dogs are more susceptible to heart disease and heart failure. Dilated cardiomyopathy (DCM) primarily affects middle-aged dogs, whereas atrioventricular valvular insufficiency (AVVI) most commonly appears in older dogs.
  • Breed: Small dogs are more susceptible to AVVI, whereas large and giant breeds are more susceptible to DCM. Also, pay attention to at-risk breeds for each disease.
    • Click here for AVVI-susceptible breeds.
    • Click here for DCM-susceptible breeds.

History: To obtain the most complete clinical history about a dog, ask the pet owner specific questions about the following factors:

  • Changes in attitude, behavior, and activity level: Exercise intolerance, depression, and fatigue are all signs associated with CHF.
  • Changes in breathing: Labored breathing or an increased resting respiratory rate can indicate CHF.
  • Changes in appetite and weight: These factors can also signal a heart problem.
  • Coughing: Include evaluation of onset and type of cough. Dogs with pulmonary edema have acute cough. Dogs with chronic heart disease have mild, intermittent cough.
  • Sleeping habits: Restlessness at night is commonly associated with CHF.
  • Previous evidence of heart disease: Heart murmurs or radiographic changes, such as an enlarged heart, can indicate heart disease.
  • Therapy: Consider any preceding treatments, including compliance with heartworm prevention programs.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.

Home Site Map Terms of Use Privacy Contact About Boehringer Ingelheim Vetmedica,Inc.
VETMEDIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.
© 2015 Boehringer Ingelheim Vetmedica, Inc.